Tolterodine 1/2 mg tabs — Membership Pricing
Tolterodine 1/2 mg tabs is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.
Tolterodine 1/2 mg tabs Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Membership pricing may be available |
| Typical Retail | $21.00 |
Membership pricing may be available; confirm the price with the dispensing pharmacy.
About Tolterodine 1/2 mg tabs
Tolterodine 1/2 mg tabs is a prescription medication. Ask your doctor if Tolterodine 1/2 mg tabs is right for you.
Other strengths and forms of Tolterodine
Conditions Treated with Tolterodine 1/2 mg tabs
How to Check Tolterodine 1/2 mg tabs Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Tolterodine 1/2 mg tabs at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Related medications
Other medications associated with the same conditions in this catalog.
Also listed for Overactive Bladder / Urge Incontinence
About Tolterodine 1/2 mg tabs
Dealing with an overactive bladder can be challenging, but medications like Tolterodine 1 2 mg tabs offer effective relief. This common prescription helps manage urgent and frequent urination, improving quality of life.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Tolterodine 1/2 mg tabs is approved for (FDA label)
DETROL Tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
Source: Read the full FDA label on DailyMed. Label effective date: February 15, 2023.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Tolterodine 1/2 mg tabs (FDA label)
The Phase 2 and 3 clinical trial program for DETROL Tablets included 3071 patients who were treated with DETROL (N=2133) or placebo (N=938). The patients were treated with 1, 2, 4, or 8 mg/day for up to 12 months. No differences in the safety profile of tolterodine were identified based on age, gender, race, or metabolism. The data described below reflect exposure to DETROL 2 mg bid in 986 patients and to placebo in 683 patients exposed for 12 weeks in five Phase 3, controlled clinical studies.
Source: FDA prescribing information (DailyMed). Set ID: 41eb00d2-64e3-4ec9-8732-4bfc81b04180. SPL document ID: f27726af-7a9b-45f4-96e0-1e90a5fdcc18. Label effective date: February 15, 2023. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Tolterodine 1/2 mg tabs (FDA label)
DETROL Tablets are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. DETROL is also contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like DETROL, are metabolized to 5-hydroxymethyl tolterodine.
Source: FDA prescribing information (DailyMed). Set ID: 41eb00d2-64e3-4ec9-8732-4bfc81b04180. SPL document ID: f27726af-7a9b-45f4-96e0-1e90a5fdcc18. Label effective date: February 15, 2023. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Warnings and precautions for Tolterodine 1/2 mg tabs (FDA label)
WARNINGS Anaphylaxis and angioedema requiring hospitalization and emergency medical treatment have occurred with the first or subsequent doses of DETROL. In the event of difficulty in breathing, upper airway obstruction, or fall in blood pressure, DETROL should be discontinued and appropriate therapy promptly provided.
Source: FDA prescribing information (DailyMed). Set ID: 41eb00d2-64e3-4ec9-8732-4bfc81b04180. SPL document ID: f27726af-7a9b-45f4-96e0-1e90a5fdcc18. Label effective date: February 15, 2023. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Drug interactions for Tolterodine 1/2 mg tabs (FDA label)
CYP3A4 Inhibitors Ketoconazole, an inhibitor of the drug metabolizing enzyme CYP3A4, significantly increased plasma concentrations of tolterodine when coadministered to subjects who were poor metabolizers (see CLINICAL PHARMACOLOGY, Variability in Metabolism and Drug-Drug Interactions ). For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (e.g., itraconazole, miconazole) or macrolide antibiotics (e.g., erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL is 1 mg twice daily (see DOSAGE AND ADMINISTRATION ).
Source: FDA prescribing information (DailyMed). Set ID: 41eb00d2-64e3-4ec9-8732-4bfc81b04180. SPL document ID: f27726af-7a9b-45f4-96e0-1e90a5fdcc18. Label effective date: February 15, 2023. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.